Murthy M S, Pande S V
Laboratory of Intermediary Metabolism, Clinical Research Institute of Montreal, Quebec, Canada.
Biochem J. 1990 Jun 15;268(3):599-604. doi: 10.1042/bj2680599.
By using octyl glucoside in the presence of glycerol, it is possible to obtain a solubilized malonyl-CoA-sensitive carnitine palmitoyltransferase (CPTo) from the outer membranes of rat liver mitochondria. H.p.l.c. on hydroxyapatite column has now allowed a clear separation of the CPTo from the malonyl-CoA-insensitive CPT activity of the inner membranes (CPTi). The separated CPTo activity showed inhibition by low micromolar concentrations of malonyl-CoA, 2-tetradecylglycidyl-CoA and etomoxir-CoA. On solubilization and fractionation, the CPTo rapidly lost activity, unlike the relatively stable CPTi activity. Reconstitution into asolectin liposomes enhanced the activity and the malonyl-CoA-sensitivity of the CPTo fractions, whereas it had no such effect on the activity or malonyl-CoA insensitivity of the CPTi fractions. A polyclonal antibody raised against the malonyl-CoA-insensitive enzyme, purified from the inner membranes, precipitated the CPTi activity, but showed no reactivity with the CPTo fractions. In Western blots, the above antibody did not react with any polypeptide of the CPTo fractions. Incubation of the outer-membrane preparations with [3H]etomoxir, in the presence of ATP and CoA, led to labelling of a 90 kDa polypeptide that in the above hydroxyapatite chromatography was eluted in the same region as the CPTo. No such polypeptide labelling was seen in the CPTi fractions. With heart and skeletal-muscle mitochondria, the correspondingly labelled polypeptide was of about 86 kDa. These results show that the CPTo and CPTi are distinct proteins, that a subunit of 90 kDa for liver and 86 kDa for muscle constitutes a component of their respective CPTo systems, and that the 66 kDa subunit of the CPTi does not constitute a part of the CPTo system.
在甘油存在的情况下使用辛基葡糖苷,有可能从大鼠肝脏线粒体的外膜中获得可溶的丙二酰辅酶A敏感的肉碱棕榈酰转移酶(CPTo)。现在,通过羟基磷灰石柱上的高效液相色谱法(H.p.l.c.)可以将CPTo与内膜中对丙二酰辅酶A不敏感的肉碱棕榈酰转移酶活性(CPTi)清晰分离。分离出的CPTo活性受到低微摩尔浓度的丙二酰辅酶A、2-十四烷基缩水甘油辅酶A和依托莫昔辅酶A的抑制。在溶解和分级分离过程中,CPTo的活性迅速丧失,这与相对稳定的CPTi活性不同。重组到大豆卵磷脂脂质体中可增强CPTo组分的活性和对丙二酰辅酶A的敏感性,而对CPTi组分的活性或对丙二酰辅酶A的不敏感性没有这种影响。针对从内膜中纯化的对丙二酰辅酶A不敏感的酶产生的多克隆抗体沉淀了CPTi活性,但与CPTo组分没有反应。在蛋白质免疫印迹法中,上述抗体与CPTo组分的任何多肽都没有反应。在外膜制剂与[3H]依托莫昔在ATP和辅酶A存在下孵育时,会导致一种90 kDa多肽的标记,在上述羟基磷灰石色谱中,该多肽在与CPTo相同的区域被洗脱。在CPTi组分中未观察到这种多肽标记。对于心脏和骨骼肌线粒体,相应标记的多肽约为86 kDa。这些结果表明,CPTo和CPTi是不同的蛋白质,肝脏中90 kDa的亚基和肌肉中86 kDa的亚基构成了它们各自CPTo系统的一个组分,并且CPTi的66 kDa亚基不构成CPTo系统的一部分。